CareLit Fachartikel

Yeast-Derived Recombinant Human Albumin (RecombuminTM)

Ballance, D.J. · AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie · 2004 · Heft 12 · S. 76 bis 3

Dokument
245258
CareLit-ID
Jahr
2004
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie
Autor:innen
Ballance, D.J.
Ausgabe
Heft 12 / 2004
Jahrgang 39
Seiten
76 bis 3
Erschienen: 2004-04-28 13:00:00
ISSN
0939-2661
DOI
10.1055/s-1999-10842-5

Zusammenfassung

An increasing number of blood proteins that were formerly only available as plasma-derived products are now becoming available as recombinant products. Such recombinant blood protein products have a number of potential advantages over their plasma-derived counterpart. With the potential for more control over the starting material, it is possible to produce a more homogeneous product and may be easier to ensure lot-to-lot consistency. The recombinant nature of the production systems generally requires that the purification of the product be more extensive, leading to a purer product. A major issue with regard to…

Schlagworte

IT SERUM AINS LITERATUR SACCHAROMYCES AINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie